Published in BMJ Open on August 28, 2017
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Whatever happened to qualitative description? Res Nurs Health (2000) 24.65
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (2015) 9.40
Risk factors for HIV infection among men who have sex with men. AIDS (2006) 7.01
Psychosocial health problems increase risk for HIV among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention. Ann Behav Med (2007) 4.00
AIDS and the health crisis of the U.S. urban poor; the perspective of critical medical anthropology. Soc Sci Med (1994) 3.02
Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS (2002) 2.57
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One (2013) 2.55
Psychosocial predictors of HIV-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for HIV infection: what works and what doesn't work? Psychosom Med (2008) 2.49
Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health (2013) 2.16
HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada. Sex Transm Infect (2004) 1.33
Viral load and HIV treatment attitudes as correlates of sexual risk behavior among HIV-positive gay men. J Psychosom Res (2003) 1.29
Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella flexneri 3a in England and Wales. Sex Transm Infect (2015) 1.21
The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men. J Acquir Immune Defic Syndr (2015) 1.19
The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee. Epidemiol Infect (1996) 1.11
Changes in HIV treatment beliefs and sexual risk behaviors among gay and bisexual men, 1997-2005. Health Psychol (2007) 1.09
Factors associated with HIV seroconversion in gay men in England at the start of the 21st century. Sex Transm Infect (2007) 1.06
Risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for HIV. Sex Transm Infect (2008) 1.04
HIV treatment optimism and high-risk sexual behaviour among gay men: the attributable population risk. AIDS (2004) 0.91
HIV treatment optimism and unsafe anal intercourse among HIV-positive men who have sex with men: findings from the positive connections study. AIDS Educ Prev (2010) 0.91
The global response to HIV in men who have sex with men. Lancet (2016) 0.91
Illicit drug use in sexual settings ('chemsex') and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect (2015) 0.85
Same-sex sexuality and psychiatric disorders in the second Netherlands Mental Health Survey and Incidence Study (NEMESIS-2). LGBT Health (2014) 0.84
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis. Trials (2016) 0.83
Young men who have sex with men's use of social and sexual media and sex-risk associations: cross-sectional, online survey across four countries. Sex Transm Infect (2016) 0.78
Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial. Lancet HIV (2015) 3.36
Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study. Lancet HIV (2014) 1.88
Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV (2014) 1.71
The SPORTSMART study: a pilot randomised controlled trial of sexually transmitted infection screening interventions targeting men in football club settings. Sex Transm Infect (2014) 0.92
Effects of age on symptom burden, mental health and quality of life amongst people with HIV in the UK. J Int AIDS Soc (2014) 0.86
Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa. J Int AIDS Soc (2017) 0.78
Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc (2017) 0.77
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. Lancet Public Health (2016) 0.75
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother (2017) 0.75
Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission. Sex Transm Infect (2017) 0.75
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. Lancet Glob Health (2017) 0.75
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses. HIV Med (2021) 0.75
Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation. Lancet Infect Dis (2017) 0.75
A community perspective on pre-exposure prophylaxis. J Int AIDS Soc (2014) 0.75
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients. AIDS Behav (2017) 0.75
Eligibility for PrEP among MSM attending GUM clinics in the UK. Sex Transm Infect (2017) 0.75